The frequency of mutations such as BRAF, PIK3CA, and AKT, which do not commonly occur in CRC patient groups, resulted in a limited number of individual tumors with positive mutation statuses in the presented cohort of 54 tumors. This evidence concerns the gene AKT1 and colorectal carcinoma.